Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 565 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Airbrushed Magazines Hurt the Body Image of Young Women — Here’s... May 19, 2021 ctDNA Sequencing Reliably Detects KIT/PDGFRA Mutations and Correlates with Outcomes in... May 23, 2023 TRACERx: Using blood tests to track lung cancer May 1, 2023 EMA Recommends Granting a Conditional Marketing Authorisation for Futibatinib April 28, 2023 Load more HOT NEWS Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With... Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients... Some Children with Liver Cancer May Need Less Chemotherapy, Study Suggests Why I Choose to Live With Gratitude During Metastatic Breast Cancer
